Eupraxia Pharmaceuticals (EPRX) Net Income (2023 - 2026)
Eupraxia Pharmaceuticals' Net Income came in at -$14.49 million for the quarter ended Jun 30, 2026, compared with -$8.75 million a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Net Income (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Eupraxia Pharmaceuticals reported Net Income of -$50.24 million; for the year ended Dec 31, 2025, it was -$38.61 million.
- Going back by year, Net Income was -$25.74 million in the year ended Dec 31, 2024, -$28.97 million in the year ended Dec 31, 2023 and -$18.99 million in the year ended Dec 31, 2022.
- The five-year range for quarterly Net Income is -$16.72 million (the quarter ended Dec 31, 2025) to -$3.96 million (the quarter ended Mar 31, 2023).
- Business Quant data shows EPRX's Net Income at -$12.65 million (quarter ended Mar 31, 2026), -$16.72 million (quarter ended Dec 31, 2025) and -$6.37 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Eupraxia Pharmaceuticals | 363.60 Mn | 362.00 Mn | - | -14.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14.49 Mn |
| Mar 31, 2026 | -12.65 Mn |
| Dec 31, 2025 | -16.72 Mn |
| Sep 30, 2025 | -6.37 Mn |
| Jun 30, 2025 | -8.75 Mn |
| Mar 31, 2025 | -6.77 Mn |
| Dec 31, 2024 | -7.53 Mn |
| Sep 30, 2024 | -5.99 Mn |
| Jun 30, 2024 | -6.06 Mn |
| Mar 31, 2024 | -6.16 Mn |
| Dec 31, 2023 | -10.61 Mn |
| Sep 30, 2023 | -4.90 Mn |
| Jun 30, 2023 | -9.51 Mn |
| Mar 31, 2023 | -3.96 Mn |
API Access
Eupraxia Pharmaceuticals Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();